Time on boards
- Boards served
- 4
- Current seats
- 4
- Board service
- 13 years
- Director since
- 2023
13 years of board service in total across 4 boards, counting each seat separately. Longest: AnaptysBio Inc., 3 years.
AnaptysBio Inc.
Director
TransCode Therapeutics Inc.
Director
Arcturus Therapeutics Holdings Inc.
Director
Immix Biopharma Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 15, 2024 | AnaptysBio Inc. | Option exercise | +3,900 | — | — |
| Jun 14, 2024 | Arcturus Therapeutics Holdings Inc. | Option exercise | +3,131 | — | — |
| May 20, 2024 | Immix Biopharma Inc. | Grant or award | +21,155 | — | — |
| May 15, 2024 | Immix Biopharma Inc. | Grant or award | +25,002 | — | — |
| Sep 6, 2023 | Immix Biopharma Inc. | Open-market purchase | +9,000 | $2.47 | $22,230 |
| Sep 5, 2023 | Immix Biopharma Inc. | Open-market purchase | +10,000 | $2.47 | $24,700 |
| Aug 31, 2023 | Immix Biopharma Inc. | Open-market purchase | +1,000 | $2.01 | $2,010 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.